Nantong JiangTian Chemical Past Earnings Performance
Past criteria checks 0/6
Nantong JiangTian Chemical's earnings have been declining at an average annual rate of -0.2%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 9.1% per year. Nantong JiangTian Chemical's return on equity is 6.9%, and it has net margins of 6.9%.
Key information
-0.2%
Earnings growth rate
-6.6%
EPS growth rate
Chemicals Industry Growth | 12.1% |
Revenue growth rate | 9.1% |
Return on equity | 6.9% |
Net Margin | 6.9% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Weak Statutory Earnings May Not Tell The Whole Story For Nantong JiangTian Chemical (SZSE:300927)
Oct 28Why Nantong JiangTian Chemical's (SZSE:300927) Shaky Earnings Are Just The Beginning Of Its Problems
Apr 25Recent updates
Weak Statutory Earnings May Not Tell The Whole Story For Nantong JiangTian Chemical (SZSE:300927)
Oct 28Optimistic Investors Push Nantong JiangTian Chemical Co., Ltd. (SZSE:300927) Shares Up 28% But Growth Is Lacking
Sep 27Be Wary Of Nantong JiangTian Chemical (SZSE:300927) And Its Returns On Capital
Sep 25Nantong JiangTian Chemical Co., Ltd.'s (SZSE:300927) 29% Share Price Surge Not Quite Adding Up
Aug 08Some Confidence Is Lacking In Nantong JiangTian Chemical Co., Ltd. (SZSE:300927) As Shares Slide 30%
Jun 22Nantong JiangTian Chemical (SZSE:300927) Will Pay A Larger Dividend Than Last Year At CN¥0.145
Jun 17Nantong JiangTian Chemical (SZSE:300927) Is Reinvesting At Lower Rates Of Return
May 31Why Nantong JiangTian Chemical's (SZSE:300927) Shaky Earnings Are Just The Beginning Of Its Problems
Apr 25There's No Escaping Nantong JiangTian Chemical Co., Ltd.'s (SZSE:300927) Muted Earnings Despite A 34% Share Price Rise
Mar 09Nantong JiangTian Chemical's (SZSE:300927) Returns On Capital Not Reflecting Well On The Business
Feb 26Revenue & Expenses Breakdown
How Nantong JiangTian Chemical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 701 | 49 | 43 | 6 |
30 Jun 24 | 701 | 54 | 42 | 7 |
31 Mar 24 | 689 | 58 | 41 | 8 |
31 Dec 23 | 709 | 69 | 42 | 8 |
30 Sep 23 | 716 | 67 | 40 | 7 |
30 Jun 23 | 720 | 63 | 43 | 7 |
31 Mar 23 | 736 | 63 | 41 | 7 |
01 Jan 23 | 737 | 64 | 42 | 6 |
30 Sep 22 | 744 | 72 | 43 | 7 |
30 Jun 22 | 739 | 75 | 41 | 7 |
31 Mar 22 | 731 | 78 | 42 | 7 |
01 Jan 22 | 710 | 76 | 41 | 7 |
30 Sep 21 | 646 | 67 | 41 | 8 |
30 Jun 21 | 575 | 66 | 38 | 7 |
31 Mar 21 | 504 | 64 | 36 | 7 |
31 Dec 20 | 438 | 55 | 31 | 7 |
30 Sep 20 | 437 | 52 | 70 | 11 |
31 Dec 19 | 500 | 54 | 49 | 7 |
01 Jan 19 | 611 | 62 | 49 | 6 |
31 Dec 17 | 496 | 40 | 42 | 7 |
31 Dec 16 | 354 | 17 | 37 | 7 |
Quality Earnings: 300927 has a high level of non-cash earnings.
Growing Profit Margin: 300927's current net profit margins (6.9%) are lower than last year (9.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300927's earnings have declined by 0.2% per year over the past 5 years.
Accelerating Growth: 300927's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300927 had negative earnings growth (-27.4%) over the past year, making it difficult to compare to the Chemicals industry average (-5.3%).
Return on Equity
High ROE: 300927's Return on Equity (6.9%) is considered low.